LIGAND PHARMACEUTICALS INCORPORATED: cash_and_equivalents
| Value | {"amount": 45006000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df326061-09f9-4d5e-aa4b-e64b12239810
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-23-000007Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/cash-and-equivalents/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df326061-09f9-4d5e-aa4b-e64b12239810
History
- no predecessors — first report